0001209191-20-055030.txt : 20201016
0001209191-20-055030.hdr.sgml : 20201016
20201016152925
ACCESSION NUMBER: 0001209191-20-055030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201014
FILED AS OF DATE: 20201016
DATE AS OF CHANGE: 20201016
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BISCHOFBERGER NORBERT W
CENTRAL INDEX KEY: 0001190273
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39592
FILM NUMBER: 201243887
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
STREET 2: C/O GILEAD SCIENCES, INC.
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kronos Bio, Inc.
CENTRAL INDEX KEY: 0001741830
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1300 S. EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN MATEO
STATE: CA
ZIP: 94402
BUSINESS PHONE: 212-871-7920
MAIL ADDRESS:
STREET 1: 1300 S. EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN MATEO
STATE: CA
ZIP: 94402
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-14
0
0001741830
Kronos Bio, Inc.
KRON
0001190273
BISCHOFBERGER NORBERT W
C/O KRONOS BIO, INC.
1300 SO. EL CAMINO REAL, SUITE 300
SAN MATEO
CA
94402
1
1
0
0
President & CEO
Common Stock
2020-10-14
4
C
0
316501
A
2437662
I
See footnote
Common Stock
2020-10-14
4
C
0
1651576
A
4089238
I
See footnote
Common Stock
2020-10-14
4
C
0
185758
16.15
A
4274996
I
See footnote
Common Stock
2020-10-14
4
P
0
95500
19.00
A
4370496
I
See footnote
Common Stock
2020-10-14
4
C
0
263750
A
263750
I
See footnote
Common Stock
2020-10-14
4
C
0
263750
A
263750
I
See footnote
Common Stock
2020-10-14
4
C
0
263750
A
263750
I
See footnote
Common Stock
2020-10-14
4
C
0
263750
A
263750
I
See footnote
Series Seed Preferred Stock
2020-10-14
4
C
0
300001
D
Common Stock
316501
0
I
See footnote
Series A Preferred Stock
2020-10-14
4
C
0
1565475
D
Common Stock
1651576
0
I
See footnote
Convertible Promissory Note
16.15
2020-10-14
4
C
0
3000000.00
0.00
D
2022-02-20
Common Stock
185758
0
I
See footnote
Series Seed Preferred Stock
2020-10-14
4
C
0
250000
D
Common Stock
263750
0
I
See footnote
Series Seed Preferred Stock
2020-10-14
4
C
0
250000
D
Common Stock
263750
0
I
See footnote
Series Seed Preferred Stock
2020-10-14
4
C
0
250000
D
Common Stock
263750
0
I
See footnote
Series Seed Preferred
2020-10-14
4
C
0
250000
D
Common Stock
263750
0
I
See footnote
Each share of Series Seed Preferred Stock and Series A Preferred Stock (the "Preferred Stock") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
By the Norbert W. & Inger A. Bischofberger Revocable Inter Vivos Trust, dtd August 29, 1994.
By Norbert W. Bischofberger and Inger A. Bischofberger, Trustees of The David Michael Anthony Dynasty GST Exempt Trust dated April 29, 2020.
By Norbert W. Bischofberger and Inger A. Bischofberger, Trustees of The David Michael Anthony Dynasty GST Non-Exempt Trust dated April 29, 2020.
By Norbert W. Bischofberger and Inger A. Bischofberger, Trustees of The Irene Alisha Bischofberger Dynasty GST Exempt Trust dated April 29, 2020.
By Norbert W. Bischofberger and Inger A. Bischofberger, Trustees of The Irene Alisha Bischofberger Dynasty GST Non-Exempt Trust dated April 29, 2020.
The convertible promissory note automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering.
/s/ David Tanen, Attorney-in-Fact
2020-10-16